Pan-Cancer Transcriptomic Analysis Identifies PLKI Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma

Background: Polo-like kinase 1 (PLK1) belongs to polo-like kinases family and affects cell cycles. However, the role of PLK1 in some malignant tumors remains unclear. Methods: To obtain a comprehensive view of PLK1 expression patterns, public databases including The Cancer Genome Atlas Cancer Cell L...

Full description

Saved in:
Bibliographic Details
Published in:Journal of inflammation research 2022-02, Vol.15, p.1099
Main Authors: Qian, Yiguan, Li, Yang, Chen, Ke, Liu, Ning, Hong, Xi, Wu, Di, Xu, Zheng, Zhou, Liuhua, Xu, Luwei, Jia, Ruipeng, Ge, Yu-Zheng
Format: Article
Language:English
Subjects:
B cells
Cancer
Carcinoma, Renal cell
Genetic aspects
Genomics
Methylation
Prognosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Polo-like kinase 1 (PLK1) belongs to polo-like kinases family and affects cell cycles. However, the role of PLK1 in some malignant tumors remains unclear. Methods: To obtain a comprehensive view of PLK1 expression patterns, public databases including The Cancer Genome Atlas Cancer Cell Line Encyclopedia, the Genotype-Tissue Expression, and human cell landscape databases were employed. The correlation of PLK1 expression with prognosis, immune infiltrations, immune checkpoint genes, tumor mutational burden (TMB), microsatellite instability (MSI), mismatch repair (MMR), and DNA methylation was examined. Besides, we validated the results of clear cell renal cell carcinoma (ccRCC) in two cohorts, with quantitative real-time PCR, Western blot, and loss-of-function experiments. Results: By mining public datasets, we discovered that PLK1 expression in tumor tissues and cancer cell lines displayed hetero-geneity compared to normal controls across different cancers. Besides, high expression of PLK1 results in shorter survival time in 15 cancer types, especially in ccRCC. PLK1 expression showed strong association with immune cell infiltration and immune checkpoint genes across cancer types. Moreover, we identified a strong association between PLK1 expression and TMB, MSI MMR, and DNA methylation. PLK1 was validated to be highly expressed in ccRCC tissues and promote ccRCC cell proliferation, migration, invasion and cell cycle. Mechanistically, PLK1 could regulate forkhead box protein M1 and target cell cycle-associated genes to participate in cell cycle control. Conclusion: PLK1 has important prognostic value and is associated with tumor immunity across cancer types including ccRCC. Keywords: PLK1, pan-cancer analysis, ccRCC, biomarker, tumor immunity
ISSN:1178-7031
1178-7031
DOI:10.2147/JIR.S347732